-
1
-
-
0004292914
-
-
Lippincott-Raven Publishers, Philadelphia, PA, USA
-
Rothman K.J., and Greenland S. Modern Epidemiology. 2nd edition (1998), Lippincott-Raven Publishers, Philadelphia, PA, USA
-
(1998)
Modern Epidemiology. 2nd edition
-
-
Rothman, K.J.1
Greenland, S.2
-
2
-
-
0003527257
-
-
Rothman K.J. (Ed), Epidemiology Resources, Boston
-
In: Rothman K.J. (Ed). Causal Inference (1988), Epidemiology Resources, Boston
-
(1988)
Causal Inference
-
-
-
3
-
-
34447627418
-
-
Hume D. A treatise of human nature. Oxford: Oxford University Press, 1888; 2nd edition, 1978 (original publication, 1739).
-
-
-
-
5
-
-
0036778489
-
Evolution of the epidemiologic context of cardiovascular diseases: a critical historical approach
-
Gensini G.F., Conti A.A., and Lippi D. Evolution of the epidemiologic context of cardiovascular diseases: a critical historical approach. Ital. Heart J 3 Suppl 6 (2002) 5S-8S
-
(2002)
Ital. Heart J
, vol.3
, Issue.SUPPL. 6
-
-
Gensini, G.F.1
Conti, A.A.2
Lippi, D.3
-
6
-
-
0033735227
-
Is evidence-based medicine really a craze? Surely it is fashionable to criticize it. A methodologic comment from the Centro Italiano per la Medicina Basata sulle Prove (Italian Center for Evidence-Based Medicine)
-
Conti A.A., Galanti C., and Gensini G.F. Is evidence-based medicine really a craze? Surely it is fashionable to criticize it. A methodologic comment from the Centro Italiano per la Medicina Basata sulle Prove (Italian Center for Evidence-Based Medicine). Ital. Heart J Suppl 1 (2000) 1192-1195
-
(2000)
Ital. Heart J
, vol.SUPPL. 1
, pp. 1192-1195
-
-
Conti, A.A.1
Galanti, C.2
Gensini, G.F.3
-
7
-
-
31844443695
-
The environment and disease: association or causation?
-
Hill A.B. The environment and disease: association or causation?. Proc. R. Soc. Med. 58 (1965) 295-300
-
(1965)
Proc. R. Soc. Med.
, vol.58
, pp. 295-300
-
-
Hill, A.B.1
-
8
-
-
0022496624
-
On the logic of causal inference
-
Weed D.L. On the logic of causal inference. Am. J. Epidemiol. 123 (1986) 965-979
-
(1986)
Am. J. Epidemiol.
, vol.123
, pp. 965-979
-
-
Weed, D.L.1
-
9
-
-
0003408870
-
-
Harris MJ. (Ed), National Institutes of Health, Bethesda, MD
-
In: Harris MJ. (Ed). Diabetes in America. 2nd edition (1995), National Institutes of Health, Bethesda, MD
-
(1995)
Diabetes in America. 2nd edition
-
-
-
10
-
-
0031851293
-
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation
-
Alberti K., and Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet. Med. 15 (1998) 539-553
-
(1998)
Diabet. Med.
, vol.15
, pp. 539-553
-
-
Alberti, K.1
Zimmet, P.2
-
11
-
-
34447643669
-
-
BMJ Clinical Evidence Online, BMJ Publishing Group, London, UK; available online at: http://www.clinicalevidence.com/ceweb/products/online_only.jsp (accessed on April 13th, 2007).
-
-
-
-
12
-
-
0029993074
-
Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs
-
Krolewski A.S., Warram J.H., and Freire M.B. Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs. Endocrinol. Metab. Clin. N. Am. 25 (1996) 217-242
-
(1996)
Endocrinol. Metab. Clin. N. Am.
, vol.25
, pp. 217-242
-
-
Krolewski, A.S.1
Warram, J.H.2
Freire, M.B.3
-
13
-
-
33745699562
-
Metabolic syndrome, new onset diabetes and new end points in cardiovascular trials
-
Haffner S.M., et al. Metabolic syndrome, new onset diabetes and new end points in cardiovascular trials. J. Cardiovasc. Pharmacol. 47 (2006) 469-475
-
(2006)
J. Cardiovasc. Pharmacol.
, vol.47
, pp. 469-475
-
-
Haffner, S.M.1
-
14
-
-
0003571561
-
-
Braunwald E., Fauci A.S., Kasper D.L., Hauser S.L., Longo D.L., and Jameson J.L. (Eds), McGraw-Hill, New York
-
In: Braunwald E., Fauci A.S., Kasper D.L., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's Principles of Internal Medicine. 15th edition (2001), McGraw-Hill, New York
-
(2001)
Harrison's Principles of Internal Medicine. 15th edition
-
-
-
15
-
-
0030746637
-
The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature
-
Dinneen S.F., and Gerstein H.C. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch. Intern. Med. 157 (1997) 1413-1438
-
(1997)
Arch. Intern. Med.
, vol.157
, pp. 1413-1438
-
-
Dinneen, S.F.1
Gerstein, H.C.2
-
16
-
-
0004225302
-
-
Goldman L., and Ausiello D. (Eds), Saunders, Philadelphia
-
In: Goldman L., and Ausiello D. (Eds). Cecil Textbook of Medicine. 22nd edition (2004), Saunders, Philadelphia
-
(2004)
Cecil Textbook of Medicine. 22nd edition
-
-
-
17
-
-
1442303535
-
-
Weatherall D.J., Cox T.M., Firth J.D., and Benz E.J. (Eds), Oxford Medical Publications, Oxford
-
In: Weatherall D.J., Cox T.M., Firth J.D., and Benz E.J. (Eds). Oxford Textbook of Medicine. 4th edition (2003), Oxford Medical Publications, Oxford
-
(2003)
Oxford Textbook of Medicine. 4th edition
-
-
-
18
-
-
34447617258
-
Update in the management of obesity
-
Suastika K. Update in the management of obesity. Acta Med. Indones. 38 (2006) 231-237
-
(2006)
Acta Med. Indones.
, vol.38
, pp. 231-237
-
-
Suastika, K.1
-
19
-
-
4644238349
-
Clinicians' manual on total risk management
-
Davenport L. (Ed), Science Press, London
-
Wood D., et al. Clinicians' manual on total risk management. In: Davenport L. (Ed). A Guide to Prevention of Coronary Heart Disease (2000), Science Press, London
-
(2000)
A Guide to Prevention of Coronary Heart Disease
-
-
Wood, D.1
-
20
-
-
33846083971
-
Primary prevention of cardiovascular diseases in people with diabetes mellitus. A scientific statement from the American Heart Association and the American Diabetes Association
-
Buse J.B., et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus. A scientific statement from the American Heart Association and the American Diabetes Association. Circulation 115 (2007) 114-126
-
(2007)
Circulation
, vol.115
, pp. 114-126
-
-
Buse, J.B.1
-
21
-
-
0033009672
-
Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review
-
Groeneveld Y., et al. Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review. Diabet. Med. 16 (1999) 2-13
-
(1999)
Diabet. Med.
, vol.16
, pp. 2-13
-
-
Groeneveld, Y.1
-
22
-
-
0027370108
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
-
DCCT Research Group
-
DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
-
(1993)
N. Engl. J. Med.
, vol.329
, pp. 977-986
-
-
-
23
-
-
0028940198
-
Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial
-
DCCT Research Group
-
DCCT Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am. J. Cardiol. 75 (1995) 894-903
-
(1995)
Am. J. Cardiol.
, vol.75
, pp. 894-903
-
-
-
24
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. UKPDS 33
-
UK Prospective Diabetes Study Group
-
UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. UKPDS 33. Lancet 352 (1998) 837-853
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
25
-
-
0032511566
-
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. UKPDS 34
-
UK Prospective Diabetes Study Group
-
UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. UKPDS 34. Lancet 352 (1998) 854-865
-
(1998)
Lancet
, vol.352
, pp. 854-865
-
-
-
26
-
-
32144442853
-
Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus
-
Vasudevan A.R., and Ballantyne C.M. Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus. Clin. Cornerstone 7 (2005) 7-16
-
(2005)
Clin. Cornerstone
, vol.7
, pp. 7-16
-
-
Vasudevan, A.R.1
Ballantyne, C.M.2
-
27
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
Hansson L., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351 (1998) 1751-1762
-
(1998)
Lancet
, vol.351
, pp. 1751-1762
-
-
Hansson, L.1
-
28
-
-
84921431153
-
Antihypertensive therapy for preventing cardiovascular complications in people with diabetes
-
Fuller J., et al. Antihypertensive therapy for preventing cardiovascular complications in people with diabetes. Cochrane Database Syst. Rev. 1 (2003) CD002188
-
(2003)
Cochrane Database Syst. Rev.
, vol.1
-
-
Fuller, J.1
-
29
-
-
4644346499
-
-
The practical implementation taskforce for the prevention of cardiovascular disease. Prevention of cardiovascular disease: an evidence-based clinical aid 2004. MJA Focus vol. 181 (2004) F1-F14
-
(2004)
MJA Focus
, vol.181
-
-
-
30
-
-
0034700790
-
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and the MICRO-HOPE substudy
-
Heart Outcomes Prevention Evaluation (HOPE) Study Investigators
-
Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and the MICRO-HOPE substudy. Lancet 355 (2000) 253-259
-
(2000)
Lancet
, vol.355
, pp. 253-259
-
-
-
31
-
-
0032511580
-
Tight blood pressure control and risk of macrovascular complications in type 2 diabetes. UKPDS 38
-
UK Prospective Diabetes Study Group
-
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular complications in type 2 diabetes. UKPDS 38. BMJ 317 (1998) 703-713
-
(1998)
BMJ
, vol.317
, pp. 703-713
-
-
-
32
-
-
0032511601
-
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 39
-
UK Prospective Diabetes Study Group
-
UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 39. BMJ 317 (1998) 713-720
-
(1998)
BMJ
, vol.317
, pp. 713-720
-
-
-
33
-
-
0035922447
-
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
-
Lewis E., et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345 (2001) 851-860
-
(2001)
N. Engl. J. Med.
, vol.345
, pp. 851-860
-
-
Lewis, E.1
-
34
-
-
0035922444
-
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
-
Parving H., et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 345 (2001) 870-878
-
(2001)
N. Engl. J. Med.
, vol.345
, pp. 870-878
-
-
Parving, H.1
-
35
-
-
0035922441
-
Effect of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
Brenner B., et al. Effect of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345 (2001) 861-869
-
(2001)
N. Engl. J. Med.
, vol.345
, pp. 861-869
-
-
Brenner, B.1
-
36
-
-
0037160969
-
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
-
Lindholm L., et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359 (2002) 1004-1010
-
(2002)
Lancet
, vol.359
, pp. 1004-1010
-
-
Lindholm, L.1
-
37
-
-
0034685403
-
Major cardiovascular events in hypertensive patients randomised to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
-
ALLHAT Collaborative Research Group
-
ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomised to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 283 (2000) 1967-1975
-
(2000)
JAMA
, vol.283
, pp. 1967-1975
-
-
-
38
-
-
0033522149
-
Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
-
Tuomilehto J., et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N. Engl. J. Med. 340 (1999) 677-684
-
(1999)
N. Engl. J. Med.
, vol.340
, pp. 677-684
-
-
Tuomilehto, J.1
-
39
-
-
0031944128
-
Outcome results of the fosinopril versus amlodipine cardiovascular events randomised trial (FACET) in patients with hypertension and NIDDM
-
Tatti P., et al. Outcome results of the fosinopril versus amlodipine cardiovascular events randomised trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 21 (1998) 597-603
-
(1998)
Diabetes Care
, vol.21
, pp. 597-603
-
-
Tatti, P.1
-
40
-
-
0032485350
-
The effect of nisoldipine as compared with enalapril on cardiovascular events in patients with NIDDM and hypertension
-
Estacio R.O., et al. The effect of nisoldipine as compared with enalapril on cardiovascular events in patients with NIDDM and hypertension. N. Engl. J. Med. 338 (1998) 645-652
-
(1998)
N. Engl. J. Med.
, vol.338
, pp. 645-652
-
-
Estacio, R.O.1
-
41
-
-
0033034404
-
Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension. The Captopril Prevention Project (CAPPP) randomised trial
-
Hansson L., et al. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension. The Captopril Prevention Project (CAPPP) randomised trial. Lancet 353 (1999) 611-616
-
(1999)
Lancet
, vol.353
, pp. 611-616
-
-
Hansson, L.1
-
42
-
-
6344246164
-
Prevention of cardiovascular complications of diabetes mellitus by aspirin
-
Nobles-James C., James E.A., and Sowers J.R. Prevention of cardiovascular complications of diabetes mellitus by aspirin. Cardiovasc. Drug Rev. 22 (2004) 215-226
-
(2004)
Cardiovasc. Drug Rev.
, vol.22
, pp. 215-226
-
-
Nobles-James, C.1
James, E.A.2
Sowers, J.R.3
-
43
-
-
0026775578
-
Aspirin effects on mortality and morbidity in patients with diabetes mellitus
-
ETDRS Investigators
-
ETDRS Investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. JAMA 268 (1992) 1292-1300
-
(1992)
JAMA
, vol.268
, pp. 1292-1300
-
-
-
44
-
-
0024406369
-
Final report on the aspirin component of the ongoing Physicians' Health Study
-
Steering Committee of the Physicians' Health Study Research Group
-
Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N. Engl. J. Med. 321 (1989) 129-135
-
(1989)
N. Engl. J. Med.
, vol.321
, pp. 129-135
-
-
-
45
-
-
0028120906
-
Collaborative overview of randomised trials of antiplatelet therapy I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration (ATC)
-
Collaborative overview of randomised trials of antiplatelet therapy I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration (ATC). BMJ 308 (1994) 81-106
-
(1994)
BMJ
, vol.308
, pp. 81-106
-
-
-
46
-
-
33750590325
-
Rising to the challenge of treating high-risk patients
-
Guthrie R.M. Rising to the challenge of treating high-risk patients. Am. J. Manag. Care 12 (2006) S318-S324
-
(2006)
Am. J. Manag. Care
, vol.12
-
-
Guthrie, R.M.1
-
47
-
-
0032572086
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
-
Downs J.R., et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279 (1998) 1615-1622
-
(1998)
JAMA
, vol.279
, pp. 1615-1622
-
-
Downs, J.R.1
-
48
-
-
0037840242
-
MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
-
Heart Protection Study Collaborative Group
-
Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361 (2003) 2005-2016
-
(2003)
Lancet
, vol.361
, pp. 2005-2016
-
-
-
49
-
-
0031922041
-
Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study
-
Elkeles R.S., et al. Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study. Diabetes Care 21 (1998) 641-648
-
(1998)
Diabetes Care
, vol.21
, pp. 641-648
-
-
Elkeles, R.S.1
-
50
-
-
0026710526
-
Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study
-
Koskinen P., et al. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 15 (1992) 820-825
-
(1992)
Diabetes Care
, vol.15
, pp. 820-825
-
-
Koskinen, P.1
-
51
-
-
0038171517
-
Evidence-based evaluation of benefits in therapeutic interventions: methodologically controlled and non-randomly assigned reflections on the number needed to treat
-
Gensini G.F., and Conti A.A. Evidence-based evaluation of benefits in therapeutic interventions: methodologically controlled and non-randomly assigned reflections on the number needed to treat. Ital. Heart J 4 (2003) 80-83
-
(2003)
Ital. Heart J
, vol.4
, pp. 80-83
-
-
Gensini, G.F.1
Conti, A.A.2
-
52
-
-
0037387809
-
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy
-
Berl T., et al. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Ann. Intern. Med. 138 (2003) 542-549
-
(2003)
Ann. Intern. Med.
, vol.138
, pp. 542-549
-
-
Berl, T.1
|